de Groot, A. F., Blok, E. J., Charehbili, A., Engels, C. C., Smit, V. T. H. B. M., Dekker-Ensink, N. G., . . . Kroep, J. R. (2019). Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy. Breast Cancer Res Treat.
Citação norma Chicagode Groot, A. F., et al. "Strong CD8+ Lymphocyte Infiltration in Combination With Expression of HLA Class I Is Associated With Better Tumor Control in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy." Breast Cancer Res Treat 2019.
MLA引文de Groot, A. F., et al. "Strong CD8+ Lymphocyte Infiltration in Combination With Expression of HLA Class I Is Associated With Better Tumor Control in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy." Breast Cancer Res Treat 2019.